Selected research
Industry Research
GLP-1 Injection Industry Research Report 2026
Market perspective
The global GLP-1 Injection market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for GLP-1 Injection is forecast to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for GLP-1 Injection is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for GLP-1 Injection is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of GLP-1 Injection include , among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global GLP-1 Injection market in revenue (US$ million) and, where applicable, sales volume (Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of types and applications, harmonizes vendor attribution, and presents comparable time series by company, type, application, and region/country, including indicative price bands (US$/Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for manufacturers, new entrants, channel partners, and investors; the report also reviews technology shifts and notable product introductions relevant to GLP-1 Injection.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
GLP-1 Injection Market by Company
Zhengda Tianqing
Innovent Biologics
Wanbang Biopharma
Sihuan Pharmaceuticals
CSPC Pharmaceutical Group
Shanghai Benemae Biopharmaceuticals Co., Ltd.
Pegbio
Eli Lilly
Huadong Medicine
Hongyun Huaning
Hengrui Medicine
Hansoh Pharmaceuticals
Gan & Lee Pharmaceuticals
Borui Pharmaceuticals
Imeik
Novo Nordisk
GLP-1 Injection Segment by Type
Benaglutide
Liraglutide
Semaglutide
Tirzepatide
Others
GLP-1 Injection Segment by Application
Diabetes
Obesity
Others
GLP-1 Injection Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global GLP-1 Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of GLP-1 Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of GLP-1 Injection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of GLP-1 Injection manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of GLP-1 Injection by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of GLP-1 Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Benaglutide
- Liraglutide
- Semaglutide
- Tirzepatide
- Others
Applications
- Diabetes
- Obesity
- Others
Companies covered
- Zhengda Tianqing
- Innovent Biologics
- Wanbang Biopharma
- Sihuan Pharmaceuticals
- CSPC Pharmaceutical Group
- Shanghai Benemae Biopharmaceuticals Co., Ltd.
- Pegbio
- Eli Lilly
- Huadong Medicine
- Hongyun Huaning
- Hengrui Medicine
- Hansoh Pharmaceuticals
- Gan & Lee Pharmaceuticals
- Borui Pharmaceuticals
- Imeik
- Novo Nordisk
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 GLP-1 Injection by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.2.2 Benaglutide
- 2.2.3 Liraglutide
- 2.2.4 Semaglutide
- 2.2.5 Tirzepatide
- 2.2.6 Others
- 2.3 GLP-1 Injection by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Diabetes
- 2.3.3 Obesity
- 2.3.4 Others
- 2.4 Global Market Growth Prospects
- 2.4.1 Global GLP-1 Injection Production Value Estimates and Forecasts (2021-2032)
- 2.4.2 Global GLP-1 Injection Production Capacity Estimates and Forecasts (2021-2032)
- 2.4.3 Global GLP-1 Injection Production Estimates and Forecasts (2021-2032)
- 2.4.4 Global GLP-1 Injection Market Average Price (2021-2032)
3 Market Competitive Landscape by Manufacturers
- 3.1 Global GLP-1 Injection Production by Manufacturers (2021-2026)
- 3.2 Global GLP-1 Injection Production Value by Manufacturers (2021-2026)
- 3.3 Global GLP-1 Injection Average Price by Manufacturers (2021-2026)
- 3.4 Global GLP-1 Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global GLP-1 Injection Key Manufacturers, Manufacturing Sites & Headquarters
- 3.6 Global GLP-1 Injection Manufacturers, Product Type & Application
- 3.7 Global GLP-1 Injection Manufacturers Established Date
- 3.8 Global GLP-1 Injection Market CR5 and HHI
- 3.9 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Zhengda Tianqing
- 4.1.1 Zhengda Tianqing GLP-1 Injection Company Information
- 4.1.2 Zhengda Tianqing GLP-1 Injection Business Overview
- 4.1.3 Zhengda Tianqing GLP-1 Injection Production, Value and Gross Margin (2021-2026)
- 4.1.4 Zhengda Tianqing Product Portfolio
- 4.1.5 Zhengda Tianqing Recent Developments
- 4.2 Innovent Biologics
- 4.2.1 Innovent Biologics GLP-1 Injection Company Information
- 4.2.2 Innovent Biologics GLP-1 Injection Business Overview
- 4.2.3 Innovent Biologics GLP-1 Injection Production, Value and Gross Margin (2021-2026)
- 4.2.4 Innovent Biologics Product Portfolio
- 4.2.5 Innovent Biologics Recent Developments
- 4.3 Wanbang Biopharma
- 4.3.1 Wanbang Biopharma GLP-1 Injection Company Information
- 4.3.2 Wanbang Biopharma GLP-1 Injection Business Overview
- 4.3.3 Wanbang Biopharma GLP-1 Injection Production, Value and Gross Margin (2021-2026)
- 4.3.4 Wanbang Biopharma Product Portfolio
- 4.3.5 Wanbang Biopharma Recent Developments
- 4.4 Sihuan Pharmaceuticals
- 4.4.1 Sihuan Pharmaceuticals GLP-1 Injection Company Information
- 4.4.2 Sihuan Pharmaceuticals GLP-1 Injection Business Overview
- 4.4.3 Sihuan Pharmaceuticals GLP-1 Injection Production, Value and Gross Margin (2021-2026)
- 4.4.4 Sihuan Pharmaceuticals Product Portfolio
- 4.4.5 Sihuan Pharmaceuticals Recent Developments
- 4.5 CSPC Pharmaceutical Group
- 4.5.1 CSPC Pharmaceutical Group GLP-1 Injection Company Information
- 4.5.2 CSPC Pharmaceutical Group GLP-1 Injection Business Overview
- 4.5.3 CSPC Pharmaceutical Group GLP-1 Injection Production, Value and Gross Margin (2021-2026)
- 4.5.4 CSPC Pharmaceutical Group Product Portfolio
- 4.5.5 CSPC Pharmaceutical Group Recent Developments
- 4.6 Shanghai Benemae Biopharmaceuticals Co., Ltd.
- 4.6.1 Shanghai Benemae Biopharmaceuticals Co., Ltd. GLP-1 Injection Company Information
- 4.6.2 Shanghai Benemae Biopharmaceuticals Co., Ltd. GLP-1 Injection Business Overview
- 4.6.3 Shanghai Benemae Biopharmaceuticals Co., Ltd. GLP-1 Injection Production, Value and Gross Margin (2021-2026)
- 4.6.4 Shanghai Benemae Biopharmaceuticals Co., Ltd. Product Portfolio
- 4.6.5 Shanghai Benemae Biopharmaceuticals Co., Ltd. Recent Developments
- 4.7 Pegbio
- 4.7.1 Pegbio GLP-1 Injection Company Information
- 4.7.2 Pegbio GLP-1 Injection Business Overview
- 4.7.3 Pegbio GLP-1 Injection Production, Value and Gross Margin (2021-2026)
- 4.7.4 Pegbio Product Portfolio
- 4.7.5 Pegbio Recent Developments
- 4.8 Eli Lilly
- 4.8.1 Eli Lilly GLP-1 Injection Company Information
- 4.8.2 Eli Lilly GLP-1 Injection Business Overview
- 4.8.3 Eli Lilly GLP-1 Injection Production, Value and Gross Margin (2021-2026)
- 4.8.4 Eli Lilly Product Portfolio
- 4.8.5 Eli Lilly Recent Developments
- 4.9 Huadong Medicine
- 4.9.1 Huadong Medicine GLP-1 Injection Company Information
- 4.9.2 Huadong Medicine GLP-1 Injection Business Overview
- 4.9.3 Huadong Medicine GLP-1 Injection Production, Value and Gross Margin (2021-2026)
- 4.9.4 Huadong Medicine Product Portfolio
- 4.9.5 Huadong Medicine Recent Developments
- 4.10 Hongyun Huaning
- 4.10.1 Hongyun Huaning GLP-1 Injection Company Information
- 4.10.2 Hongyun Huaning GLP-1 Injection Business Overview
- 4.10.3 Hongyun Huaning GLP-1 Injection Production, Value and Gross Margin (2021-2026)
- 4.10.4 Hongyun Huaning Product Portfolio
- 4.10.5 Hongyun Huaning Recent Developments
- 4.11 Hengrui Medicine
- 4.11.1 Hengrui Medicine GLP-1 Injection Company Information
- 4.11.2 Hengrui Medicine GLP-1 Injection Business Overview
- 4.11.3 Hengrui Medicine GLP-1 Injection Production, Value and Gross Margin (2021-2026)
- 4.11.4 Hengrui Medicine Product Portfolio
- 4.11.5 Hengrui Medicine Recent Developments
- 4.12 Hansoh Pharmaceuticals
- 4.12.1 Hansoh Pharmaceuticals GLP-1 Injection Company Information
- 4.12.2 Hansoh Pharmaceuticals GLP-1 Injection Business Overview
- 4.12.3 Hansoh Pharmaceuticals GLP-1 Injection Production, Value and Gross Margin (2021-2026)
- 4.12.4 Hansoh Pharmaceuticals Product Portfolio
- 4.12.5 Hansoh Pharmaceuticals Recent Developments
- 4.13 Gan & Lee Pharmaceuticals
- 4.13.1 Gan & Lee Pharmaceuticals GLP-1 Injection Company Information
- 4.13.2 Gan & Lee Pharmaceuticals GLP-1 Injection Business Overview
- 4.13.3 Gan & Lee Pharmaceuticals GLP-1 Injection Production, Value and Gross Margin (2021-2026)
- 4.13.4 Gan & Lee Pharmaceuticals Product Portfolio
- 4.13.5 Gan & Lee Pharmaceuticals Recent Developments
- 4.14 Borui Pharmaceuticals
- 4.14.1 Borui Pharmaceuticals GLP-1 Injection Company Information
- 4.14.2 Borui Pharmaceuticals GLP-1 Injection Business Overview
- 4.14.3 Borui Pharmaceuticals GLP-1 Injection Production, Value and Gross Margin (2021-2026)
- 4.14.4 Borui Pharmaceuticals Product Portfolio
- 4.14.5 Borui Pharmaceuticals Recent Developments
- 4.15 Imeik
- 4.15.1 Imeik GLP-1 Injection Company Information
- 4.15.2 Imeik GLP-1 Injection Business Overview
- 4.15.3 Imeik GLP-1 Injection Production, Value and Gross Margin (2021-2026)
- 4.15.4 Imeik Product Portfolio
- 4.15.5 Imeik Recent Developments
- 4.16 Novo Nordisk
- 4.16.1 Novo Nordisk GLP-1 Injection Company Information
- 4.16.2 Novo Nordisk GLP-1 Injection Business Overview
- 4.16.3 Novo Nordisk GLP-1 Injection Production, Value and Gross Margin (2021-2026)
- 4.16.4 Novo Nordisk Product Portfolio
- 4.16.5 Novo Nordisk Recent Developments
5 Global GLP-1 Injection Production by Region
- 5.1 Global GLP-1 Injection Production Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.2 Global GLP-1 Injection Production by Region: 2021-2032
- 5.2.1 Global GLP-1 Injection Production by Region: 2021-2026
- 5.2.2 Global GLP-1 Injection Production Forecast by Region (2027-2032)
- 5.3 Global GLP-1 Injection Production Value Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.4 Global GLP-1 Injection Production Value by Region: 2021-2032
- 5.4.1 Global GLP-1 Injection Production Value by Region: 2021-2026
- 5.4.2 Global GLP-1 Injection Production Value Forecast by Region (2027-2032)
- 5.5 Global GLP-1 Injection Market Price Analysis by Region (2021-2026)
- 5.6 Global GLP-1 Injection Production and Value, YOY Growth
- 5.6.1 North America GLP-1 Injection Production Value Estimates and Forecasts (2021-2032)
- 5.6.2 Europe GLP-1 Injection Production Value Estimates and Forecasts (2021-2032)
- 5.6.3 China GLP-1 Injection Production Value Estimates and Forecasts (2021-2032)
- 5.6.4 Japan GLP-1 Injection Production Value Estimates and Forecasts (2021-2032)
6 Global GLP-1 Injection Consumption by Region
- 6.1 Global GLP-1 Injection Consumption Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 6.2 Global GLP-1 Injection Consumption by Region (2021-2032)
- 6.2.1 Global GLP-1 Injection Consumption by Region: 2021-2026
- 6.2.2 Global GLP-1 Injection Forecasted Consumption by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America GLP-1 Injection Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America GLP-1 Injection Consumption by Country (2021-2032)
- 6.3.3 United States
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe GLP-1 Injection Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe GLP-1 Injection Consumption by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Russia
- 6.4.8 Spain
- 6.4.9 Netherlands
- 6.4.10 Switzerland
- 6.4.11 Sweden
- 6.4.12 Poland
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific GLP-1 Injection Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific GLP-1 Injection Consumption by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 India
- 6.5.7 Australia
- 6.5.8 Taiwan
- 6.5.9 Southeast Asia
- 6.6 South America, Middle East & Africa
- 6.6.1 South America, Middle East & Africa GLP-1 Injection Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East & Africa GLP-1 Injection Consumption by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 Argentina
- 6.6.5 Chile
- 6.6.6 Turkey
- 6.6.7 GCC Countries
7 Segment by Type
- 7.1 Global GLP-1 Injection Production by Type (2021-2032)
- 7.1.1 Global GLP-1 Injection Production by Type (2021-2032) & (Units)
- 7.1.2 Global GLP-1 Injection Production Market Share by Type (2021-2032)
- 7.2 Global GLP-1 Injection Production Value by Type (2021-2032)
- 7.2.1 Global GLP-1 Injection Production Value by Type (2021-2032) & (US$ Million)
- 7.2.2 Global GLP-1 Injection Production Value Market Share by Type (2021-2032)
- 7.3 Global GLP-1 Injection Price by Type (2021-2032)
8 Segment by Application
- 8.1 Global GLP-1 Injection Production by Application (2021-2032)
- 8.1.1 Global GLP-1 Injection Production by Application (2021-2032) & (Units)
- 8.1.2 Global GLP-1 Injection Production Market Share by Application (2021-2032)
- 8.2 Global GLP-1 Injection Production Value by Application (2021-2032)
- 8.2.1 Global GLP-1 Injection Production Value by Application (2021-2032) & (US$ Million)
- 8.2.2 Global GLP-1 Injection Production Value Market Share by Application (2021-2032)
- 8.3 Global GLP-1 Injection Price by Application (2021-2032)
9 Value Chain and Sales Channels Analysis of the Market
- 9.1 GLP-1 Injection Value Chain Analysis
- 9.1.1 GLP-1 Injection Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 GLP-1 Injection Production Mode & Process
- 9.2 GLP-1 Injection Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 GLP-1 Injection Distributors
- 9.2.3 GLP-1 Injection Customers
10 Global GLP-1 Injection Analyzing Market Dynamics
- 10.1 GLP-1 Injection Industry Trends
- 10.2 GLP-1 Injection Industry Drivers
- 10.3 GLP-1 Injection Industry Opportunities and Challenges
- 10.4 GLP-1 Injection Industry Restraints
11 Report Conclusion
12 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst